DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action.

By R. Palchaudhuri, P. Hergenrother. Current Opinion in Biotechnology, 2007

652 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Binding of DNA with Rhodamine B: Spectroscopic and molecular modeling studies (2013, background): “The study of anti-carcinogenic medicines and their interactions with DNA are also significantly important to develop new cancer therapy treatments [5,6].”